NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers

Not Applicable

• Conditions: Nurse Training; Alzheimer Disease
• Interventions: Behavioral: RDAD Training

• Registration Number: NCT03289377
• Lead Sponsor: University of Washington

Brief Summary

An multi-stage mixed-method design will be employed to obtain both qualitative and quantitative data to address two study aims: (1) Evaluate and refine the delivery Reducing Disabilities in Alzheimer's Disease (RD- AD) training to advanced practice nurses and (2) Evaluate and refine the implementation of RD-AD by advanced practice nurses in their medical settings.

Detailed Description

Two waves of APNs (25 each wave/total 50) will receive RDAD training and be queried pre and post- training using both qualitative and quantitative procedures to determine: (1) Is RDAD training successfully received by advanced practice nurses? (2) Do they report it as relevant to improving the care they deliver to persons with Alzheimer's Disease and Related Dementias (ADRD)? (3) Does RDAD training of advanced practice nurses improve their level of knowledge about ADRD, their skills in providing ADRD care, and their level of confidence in providing this care?

A subset of advanced practice nurses (5 per wave, total of 10) will be recruited to implement RDAD as part of their ongoing care of persons with ADRD.

Study Timeline

• Study First Submitted: 2017-09-14
• Study First Submitted QC: 2017-09-15
• Study First Posted: 2017-09-21
• Study Start: 2018-02-01
• Status Verified: 2018-05
• Last Update Submitted: 2018-05-09
• Last Update Posted: 2018-05-15
• Primary Completion: 2018-10
• Study Completion: 2018-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Licensed by the Washington state Department of Health as an Advanced Registered Nurse Practitioner (ARNP),
• Hold a board certification as a Gerontological Nurse Practitioner, Adult Nurse Practitioner, or Family Nurse Practitioner,
• Work at least half time (0.50 FTE) in a clinical setting (primary care, internal medicine, sub-specialty, medical home), with a panel consisting of over 25% of patients over 65 years of age,
• Have no expectation for termination over the course of the study; and
• Agree to participate in all phases of the RDAD translational program.

Exclusion Criteria

• NA

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
RDAD training to APNs	RDAD Training	Half-day workshop to provide APNs with all skills necessary to conduct RDAD in their clinical settings. A subset of the trained APNs will implement RDAD as part of their ongoing care of persons with ADRD.

Primary Outcome Measures

Name	Time	Method
Physician Confidence in Dementia Care Skills	Change from baseline score at 2 months	A 12-item self-report measure (administered to ARNPs) designed to measure perception of ability to address the care needs of patients with ADRD.
Sense of Competence in Dementia	Change from baseline score at 2 months	A 17-item questionnaire covering 4 domains: job satisfaction, attitude towards dementia, work experience, and level of dementia knowledge.
Dementia Attitudes Scale	Change from baseline score at 2 months	A 20-item scale to measures attitudes towards dementia with a two-factor structure; "dementia knowledge" and "social comfort".

Secondary Outcome Measures

Name	Time	Method
Focus Group Questions	At 2 months	Questions to determine satisfaction with a acceptability of RDAD
Implementation Questions	At 2 months	Questions to determine Acceptability of RDAD

Trial Locations

Locations (1)

University of Washington; 🇺🇸 Seattle, Washington, United States